PIP
ADAP

Palisades Investment Partners’s Adaptimmune Therapeutics ADAP Stock Holding History

Palisades Investment Partners’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-47,114
Closed -$25.4K – 41
2024
Q4 		$25.4K Buy
47,114
+3,659
+8% +$1.97K 0.01% 41
2024
Q3 		$41.3K Buy
+43,455
New +$41.3K 0.02% 40